Skip to main content
Log in

Obesity and fat quantification in lean tissues using three-point Dixon MR imaging

  • Original Article
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

Background: It has been suggested that increased hepatic and intramuscular fat is associated with insulin resistance, and that increased pancreatic fat is related to impaired insulin secretion. Objective: We postulated that in obese nondiabetic teenagers insulin levels would be directly related to increases in intramuscular and hepatic fat and inversely related to increases in pancreatic fat. Materials and methods: MRI was used to assess the percentage of fat in the liver, muscle and pancreas in 15 healthy Mexican-American girls, 14–17 years old, with body mass indexes (BMIs) ranging from 17.7 kg/m2 to 46 kg/m2. Results: Strong correlations were observed between BMI and fat content in the liver, muscle, and pancreas (r2s between 0.50 and 0.89; P<0.003). Serum insulin levels were closely associated with fat measures in the muscle and liver (r2s=0.63 and 0.29, and P=0.001 and P=0.023, respectively). In contrast to our hypothesis, fat content in the pancreas was also directly related to insulin secretion (r2=0.74; P=0.001). Summary: We conclude that in nondiabetic teenagers, obesity is associated with an increased accumulation of fat in the pancreas without impairment of insulin secretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Zimmet PZ (1999) Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetologia 42:499–518

    Article  Google Scholar 

  2. Miller J, Rosenbloom A, Silverstein J (2004) Childhood obesity. J Clin Endocrinol Metab 89:4211–4218

    Google Scholar 

  3. Fagot-Campagna A (2000) Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Pediatr Endocrinol Metab 13[Suppl 6]:1395–1402

    Google Scholar 

  4. Aye T, Levitsky LL (2003) Type 2 diabetes: an epidemic disease in childhood. Curr Opin Pediatr 15:411–415

    Google Scholar 

  5. Katzmarzyk PT (2002) The Canadian obesity epidemic, 1985–1998. CMAJ 166:1039–1040

    Google Scholar 

  6. Mokdad AH, Serdula MK, Dietz WH, et al (1999) The spread of the obesity epidemic in the United States, 1991–1998. JAMA 282:1519–1522

    Google Scholar 

  7. Schaffer JE (2003) Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14:281–287

    Google Scholar 

  8. Poitout V (2004) Beta-cell lipotoxicity: burning fat into heat? Endocrinology 145:3563–3565

    Google Scholar 

  9. Carpentier A, Mittelman SD, Bergman RN, et al (2000) Prolonged elevation of plasma-free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 49:399–408

    Google Scholar 

  10. Lee Y, Hirose H, Ohneda M, et al (1994) Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci USA 91:10878–10882

    Google Scholar 

  11. McGarry JD (2001) Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7–18

    Google Scholar 

  12. Unger RH (2002) Lipotoxic diseases. Annu Rev Med 53:319–336

    Article  CAS  PubMed  Google Scholar 

  13. Dixon W (1984) Simple proton spectroscopic imaging. Radiology 153:189–194

    Google Scholar 

  14. Tanner JM (1978) Physical growth and development. In: Forfar JO, Arnell CC (eds) Textbook of Pediatrics. Churchill Livingstone, Edinburgh, pp 249–303

    Google Scholar 

  15. Desbuquois B, Aurbach GD (1971) Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33:732–738

    Google Scholar 

  16. Stenman UH, Pesonen K, Ylinen K, et al (1984) Rapid chromatographic quantitation of glycosylated haemoglobins. J Chromatogr 297:327–332

    Article  CAS  PubMed  Google Scholar 

  17. Yki-Jarvinen H, Kauppila M, Kujansuu E, et al (1992) Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 327:1426–1433

    Google Scholar 

  18. Perseghin G, Scifo P, De Cobelli F, et al (1999) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600–1606

    CAS  PubMed  Google Scholar 

  19. Glover G, Schneider E (1991) Three-point Dixon technique for true water/fat decomposition with BO inhomogeneity correction. Magn Reson Med 18:371–383

    Google Scholar 

  20. Glover GH (1991) Multipoint Dixon technique for water and fat proton and susceptibility imaging. J Magn Reson Imaging 1:521–530

    Google Scholar 

  21. Guclu CC, Kovanlikaya I, Desai C, et al (2004) Lipid percentage measurements using three-point Dixon method. In: Proceedings of the 12th Annual Meeting of the ISMRM, Kyoto, 497 p

  22. Bell DSH (2004) Management of type 2 diabetes with thiazolidinediones: link between β-cell preservation and durability of response. Endocrinologist 14:293–300

    Google Scholar 

  23. Zhou YP, Ling ZC, Grill VE (1996) Inhibitory effects of fatty acids on glucose-regulated β-cell function: association with increased islet triglyceride stores and altered effect of fatty acid oxidation on glucose metabolism. Metabolism 45:981–986

    Google Scholar 

  24. Unger RH (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44:863–870

    CAS  PubMed  Google Scholar 

  25. Iannucci A, Mukai K, Johnson D, et al (1984) Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol 15:278–284

    Google Scholar 

  26. Moran A (1999) Cystic fibrosis related diabetes. In: Cystic Fibrosis Worldwide website http://www.cfww.org/pub/newsletter/nl01a/nl01af.htm

  27. Shimabukuro M, Zhou YT, Lee Y, et al (1998) Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J Biol Chem 273:3547–3550

    Article  CAS  PubMed  Google Scholar 

  28. Lister CA, Moore GBT, Piercy V, et al (1999) Rosiglitazone, but not metformin or glibenclamide, improves glycaemic control and increases islet insulin content. Diabetologia 42:A150

    Google Scholar 

  29. Finegood DT, McArthur MD, Kojwang D, et al (2001) Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 50:1021–1029

    CAS  PubMed  Google Scholar 

  30. Group. UKPS (1995) UK Prospective Diabetes Study 16. Overview of 6 years therapy of type 2 diabetes: a progressive disease. Diabetes 44:1249–1258

    Google Scholar 

  31. Netter FH (1970) The CIBA collection of medical illustrations: endocrine system and selected metabolic diseases. CIBA, New York

    Google Scholar 

  32. Schmitz-Moormann P, Pittner PM, Heinze W (1981) Lipomatosis of the pancreas. A morphometrical investigation. Pathol Res Pract 173:45–53

    Google Scholar 

  33. Cnop M, Grupping A, Hoorens A, l et al (2000) Endocytosis of low-density lipoprotein by human pancreatic beta cells and uptake in lipid-storing vesicles, which increase with age. Am J Pathol 156:237–244

    Google Scholar 

  34. Weichselbaum A, Stangl E (1902) Wien Klin Wochenschr 15:969–976

    Google Scholar 

Download references

Acknowledgements

The authors would like to express their acknowledgement of and appreciation for the support of General Electric Medical Systems, Milwaukee, Wisconsin, USA.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vicente Gilsanz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kovanlikaya, A., Mittelman, S.D., Ward, A. et al. Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr Radiol 35, 601–607 (2005). https://doi.org/10.1007/s00247-005-1413-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-005-1413-y

Keywords

Navigation